Skin allograft rejection in CD28-deficient mice

Area of Science:

• Immunology
• Transplantation immunology

Background:

• Costimulatory signals, particularly between CD28 and the B7 family, are known to enhance T cell responses.
• The precise role of CD28-mediated costimulation in allogeneic responses requires further elucidation.

Purpose of the Study:

• To investigate the necessity of CD28 costimulatory signals for the induction of alloreactive effector functions.
• To assess the impact of CD28 deficiency on T cell proliferation, cytokine production, cytotoxic activity, and skin allograft rejection.

Main Methods:

• Utilized CD28-deficient mice to examine allogeneic T cell responses.
• Performed in vitro assays to measure T cell proliferation and cytokine production.
• Assessed in vitro cytotoxic activity against allogeneic target cells.
• Evaluated in vivo skin allograft rejection in CD28-deficient recipients.

Main Results:

• T cells from CD28-deficient mice exhibited reduced proliferation and cytokine production in response to allogeneic stimulator cells in vitro.
• Despite reduced proliferation, CD28-deficient T cells developed significant cytotoxic activity against allogeneic target cells in vitro.
• CD28-deficient mice efficiently rejected skin allografts in vivo, indicating intact effector functions.

Conclusions:

• Costimulatory signals generated through CD28 are not essential for the development of alloreactive cytotoxic T lymphocyte effector functions.
• CD28-mediated costimulation is dispensable for efficient skin allograft rejection in vivo.
• Alloreactive effector functions can be induced independently of CD28 costimulation.